Linical Co., Ltd.

Symbol: 2183.T

JPX

389

JPY

Market price today

  • 12.9133

    P/E Ratio

  • -0.2306

    PEG Ratio

  • 8.79B

    MRK Cap

  • 0.04%

    DIV Yield

Linical Co., Ltd. (2183-T) Stock Price & Analysis

Shares Outstanding

22.59M

Gross Profit Margin

0.32%

Operating Profit Margin

0.09%

Net Profit Margin

0.05%

Return on Assets

0.04%

Return on Equity

0.09%

Return on Capital Employed

0.11%

Company general description and statistics

Sector: Healthcare
Industry: Biotechnology
CEO:Mr. Kazuhiro Hatano
Full-time employees:759
City:Osaka
Address:Shin-Osaka Brick Building
IPO:2008-10-27
CIK:

Linical Co., Ltd. provides drug development services primarily in the areas of oncology and central nervous system to pharmaceutical companies worldwide. The company offers drug development consulting services, such as market analysis of products in development, regulatory affairs consultation support, and licensing support. It also provides clinical research and development, and contract medical affairs services, including front-end services comprising project management, monitoring, quality control, vendor management, auditing, and clinical research secretariat; and back-end services, which include data management, bio statistical analysis, medical writing, pharmacovigilance, and medical management. The company was incorporated in 2005 and is headquartered in Osaka, Japan.

General Outlook

In simple terms, Linical Co., Ltd. has 22.586 M shares that people are buying and selling right now. When we look at how much money they make before expenses, they keep 0.324% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is 0.092%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of 0.054%. This tells us they're good at keeping money after all costs.

Return on Investments

The company's asset efficiency, represented by a robust 0.038% return, is a testament to Linical Co., Ltd.'s adeptness in optimizing resource deployment. Linical Co., Ltd.'s utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of 0.088%. Furthermore, the proficiency of Linical Co., Ltd. in capital utilization is underscored by a remarkable 0.111% return on capital employed.

Stock Prices

Linical Co., Ltd.'s stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $396, while its low point bottomed out at $387. This variance in figures offers investors a lucid insight into the roller-coaster ride that is Linical Co., Ltd.'s stock market.

Liquidity Ratios

Analyzing 2183.T liquidity ratios reveals its financial health of the firm. The current ratio of 171.22% gauges short-term asset coverage for liabilities. The quick ratio (146.72%) assesses immediate liquidity, while the cash ratio (101.75%) indicates cash reserves.

cards.indicatorcards.value
Current Ratio171.22%
Quick Ratio146.72%
Cash Ratio101.75%

Profitability Ratios

2183.T profitability indicators offer a lens into its earnings landscape. A pretax profit margin of 8.60% underscores its earnings before tax deductions. The effective tax rate stands at 36.80%, revealing its tax efficiency. The net income per EBT, 63.20%, and the EBT per EBIT, 93.00%, provide insights into its earnings hierarchy. Lastly, with an EBIT per revenue ratio of 9.25%, we grasp its operational profitability.

cards.indicatorcards.value
Pretax Profit Margin8.60%
Effective Tax Rate36.80%
Net Income per EBT63.20%
EBT per EBIT93.00%
EBIT per Revenue9.25%

Operational Efficiency

Operational metrics shed light on its business agility. With an operating cycle of 1.71, it details the span from stock purchase to revenue. The 1 days it takes to settle debts showcases its creditor relations. Meanwhile, a 1 cash conversion cycle and 385.92% receivables turnover rate reflect its cash flow efficiency and credit management, respectively.

cards.indicatorcards.value
Days of Sales Outstanding147
Operating Cycle94.58
Days of Payables Outstanding5
Cash Conversion Cycle89
Receivables Turnover3.86
Payables Turnover69.77
Fixed Asset Turnover24.57
Asset Turnover0.71

Cash Flow Ratios

Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, 44.92, and free cash flow per share, 44.92, depict cash generation on a per-share basis. The cash per share value, 325.05, showcases liquidity position. Lastly, the operating cash flow sales ratio, 0.08, offers insight into cash flow relative to sales.

cards.indicatorcards.value
Operating Cash Flow per Share44.92
Free Cash Flow per Share44.92
Cash per Share325.05
Operating Cash Flow Sales Ratio0.08
Free Cash Flow to Operating Cash Flow Ratio1.00
Cash Flow Coverage Ratio0.37
Short Term Coverage Ratio0.90

Debt and Leverage Ratios

Diving into debt and leverage metrics unveils the company's financial structure. The debt ratio, at 15.43%, highlights its total liabilities relative to assets. With a debt-equity ratio of 0.35, we discern the balance between debt and equity financing. The long-term debt to capitalization, 16.98%, and total debt to capitalization, 25.86%, ratios shed light on its capital structure. An interest coverage of 71.54 indicates its ability to manage interest expenses.

cards.indicatorcards.value
Debt Ratio15.43%
Debt Equity Ratio0.35
Long Term Debt to Capitalization16.98%
Total Debt to Capitalization25.86%
Interest Coverage71.54
Cash Flow to Debt Ratio0.37
Company Equity Multiplier2.26

Growth Ratios

Delving into growth metrics provides a snapshot of financial expansion. The revenue growth rate, 12.41%, indicates top-line expansion, while the gross profit growth, 30.49%, reveals profitability trends. EBIT growth, 139.48%, and operating income growth, 139.48%, offer insights into operational profitability progression. The net income growth, 46.40%, showcases bottom-line expansion, and the EPS growth, 46.38%, measures the growth in earnings per share.

cards.indicatorcards.value
Revenue Growth12.41%
Gross Profit Growth30.49%
EBIT Growth139.48%
Operating Income Growth139.48%
Net Income Growth46.40%
EPS Growth46.38%
EPS Diluted Growth46.38%
Dividends per Share Growth-0.08%
Operating Cash Flow Growth6811.45%
Free Cash Flow Growth3631.49%
10-Year Revenue Growth per Share223.93%
5-Year Revenue Growth per Share27.60%
3-Year Revenue Growth per Share2.46%
10-Year Operating CF Growth per Share81.09%
5-Year Operating CF Growth per Share20.74%
3-Year Operating CF Growth per Share305.43%
10-Year Net Income Growth per Share29.32%
5-Year Net Income Growth per Share-38.62%
3-Year Net Income Growth per Share64.18%
10-Year Shareholders Equity Growth per Share316.68%
5-Year Shareholders Equity Growth per Share26.52%
3-Year Shareholders Equity Growth per Share25.00%
10-Year Dividend per Share Growth per Share154.87%
5-Year Dividend per Share Growth per Share39.83%
3-Year Dividend per Share Growth per Share26.82%
Asset Growth2.85%
Book Value per Share Growth14.54%
Debt Growth-12.53%

Valuation Ratios

Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, 1.12, and the price to book ratio, 1.12, reflect the market's valuation relative to the company's book value. The price to sales ratio, 0.70, provides a perspective on valuation in relation to sales. Ratios like price to free cash flows, 8.66, and price to operating cash flows, 8.66, gauge market valuation against cash flow metrics.

cards.indicatorcards.value
Price Book Value Ratio1.12
Price to Book Ratio1.12
Price to Sales Ratio0.70
Price Cash Flow Ratio8.66
Price Earnings to Growth Ratio-0.23
Enterprise Value Multiple9.56
Price Fair Value1.12
Price to Operating Cash Flow Ratio8.66
Price to Free Cash Flows Ratio8.66
security
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
Eugene Alexeev
NumFin Founder and investing enthusiast

Frequently Asked Question

How many company shares are outstanding in 2024?

There are stock number shares outstanding of Linical Co., Ltd. (2183.T) on the JPX in 2024.

What is P/E ratio of enterprise in 2024?

The current P/E ratio of enterprise is 12.913 in 2024.

What is the ticker symbol of Linical Co., Ltd. stock?

The ticker symbol of Linical Co., Ltd. stock is 2183.T.

What is company IPO date?

IPO date of Linical Co., Ltd. is 2008-10-27.

What is company current share price?

Current share price is 389.000 JPY.

What is stock market cap today?

The market cap of stock today is 8786123604.000.

What is PEG ratio in 2024?

The current -0.231 is -0.231 in 2024.

What is the number of employees in 2024?

In 2024 the company has 759.